Researchers developed a way to directly reprogram human glial cells into PV interneurons without passing through a stem‑cell stage.

Researchers at Lund University in Sweden have created a method that makes it possible to transform the brain’s support cells ...

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, ...

Understanding why cancer cells rely on specific genes is critical for designing effective targeted therapies. A new study ...

Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced preliminary in ...

Recent findings reveal Cornell prime dots can activate the immune system against melanoma, improving cancer immunotherapy ...

Regulatory alignment supports rapid progress, tech transfer already underway to accelerate clinical readiness Company on ...

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions The latest update is out from Genprex ( (GNPX) ). On January 6, 2026, Genprex reported positive preliminary ...

Stanford scientists discover how blocking 15-PGDH protein regenerates knee cartilage in mice and human tissue, offering hope ...

A class of ultrasmall fluorescent core-shell silica nanoparticles developed at Cornell is showing an unexpected ability to ...

A new Science study shows that blocking an ageing-linked protein can regenerate knee cartilage and prevent arthritis in mice, ...

TangGene names former GSK SVP Catherine Sohn as Senior Strategic Advisor, strengthening leadership as it advances a first-in-class in-vivo CD8⁺ Treg therapy. TangGene’s in-vivo CD8⁺ Treg approach has ...